HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert J Matusik Selected Research

Androgens

9/2016Activation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progression.
3/2016Nfib Regulates Transcriptional Networks That Control the Development of Prostatic Hyperplasia.
4/2014Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer.
8/2008The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.
6/2008Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.
1/2008Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells.
10/2006Androgen-dependent prostate epithelial cell selection by targeting ARR(2)PBneo to the LPB-Tag model of prostate cancer.
7/2006Expression and role of Foxa proteins in prostate cancer.
4/2006Murine androgen-independent neuroendocrine carcinoma promotes metastasis of human prostate cancer cell line LNCaP.
10/2005Molecular alterations in primary prostate cancer after androgen ablation therapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert J Matusik Research Topics

Disease

29Prostatic Neoplasms (Prostate Cancer)
04/2022 - 05/2003
25Neoplasms (Cancer)
11/2020 - 05/2003
8Carcinogenesis
11/2020 - 07/2006
5Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2021 - 09/2002
5Neoplasm Metastasis (Metastasis)
08/2013 - 05/2003
5Prostatic Intraepithelial Neoplasia
05/2013 - 09/2002
4Adenocarcinoma
01/2021 - 07/2006
4Carcinoma (Carcinomatosis)
08/2013 - 05/2003
3Hyperplasia
10/2022 - 02/2009
3Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
05/2014 - 10/2009
3Neuroendocrine Carcinoma
07/2006 - 01/2004
2Disease Progression
01/2022 - 01/2021
2Inflammation (Inflammations)
04/2016 - 01/2008
2Hypoxia (Hypoxemia)
10/2013 - 10/2012
2Urinary Bladder Neoplasms (Bladder Cancer)
08/2013 - 01/2012
1Lower Urinary Tract Symptoms
01/2021
1Metaplasia
05/2015
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
11/2014
1Hypertrophy
10/2009
1Neurogenic Urinary Bladder (Bladder, Neurogenic)
10/2009
1Fibrosis (Cirrhosis)
10/2009
1Urinary Bladder Diseases (Bladder Diseases)
10/2008
1Small Cell Carcinoma
07/2006

Drug/Important Bio-Agent (IBA)

12AndrogensIBA
09/2016 - 01/2004
7Androgen Receptors (Androgen Receptor)IBA
09/2016 - 01/2004
6Proteins (Proteins, Gene)FDA Link
08/2013 - 07/2006
5Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2008
4Tumor Viral Antigens (Large T Antigen)IBA
05/2013 - 05/2003
4Hormones (Hormone)IBA
02/2009 - 01/2004
3NF-kappa B (NF-kB)IBA
04/2016 - 08/2008
3Phenobarbital (Luminal)FDA Link
03/2016 - 07/2014
2EnzymesIBA
11/2020 - 05/2003
2histone H3 trimethyl Lys4IBA
11/2020 - 01/2015
2Lysine (L-Lysine)FDA Link
11/2020 - 01/2015
2Histones (Histone)IBA
11/2020 - 01/2015
2UbiquitinIBA
05/2015 - 04/2014
2CateninsIBA
11/2014 - 11/2010
2Cadherins (E-Cadherin)IBA
10/2014 - 01/2012
2Transforming Growth Factors (Transforming Growth Factor)IBA
10/2009 - 05/2003
2Transforming Growth Factor beta (TGF-beta)IBA
10/2009 - 05/2003
2Transforming Growth Factor-beta Type II ReceptorIBA
10/2009 - 05/2003
2probasinIBA
01/2004 - 05/2003
1Dihydrotestosterone (Androstanolone)IBA
10/2022
1GlucocorticoidsIBA
10/2022
15-alpha Reductase InhibitorsIBA
10/2022
1alpha-2-HS-GlycoproteinIBA
04/2022
1Blood Proteins (Serum Proteins)IBA
04/2022
1Sterol Regulatory Element Binding Protein 1IBA
01/2022
1Androgen Antagonists (Antiandrogens)IBA
01/2021
1ProstaglandinsIBA
01/2021
1enzalutamideIBA
01/2021
1Small Interfering RNA (siRNA)IBA
01/2021
1alpha Adrenergic ReceptorsIBA
01/2021
1OsteopontinIBA
01/2020
1LigandsIBA
04/2016
1DNA (Deoxyribonucleic Acid)IBA
03/2016
1ChromatinIBA
03/2016
1Keratin-14 (Keratin 14)IBA
05/2015
1TamoxifenFDA LinkGeneric
11/2014
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
10/2014
1PeptidomimeticsIBA
07/2014
1F2-Isoprostanes (F2 Isoprostanes)IBA
05/2014
1Hematoxylin (Haematoxylon)IBA
10/2013
1Eosine Yellowish-(YS) (Eosin)IBA
10/2013
1Biomarkers (Surrogate Marker)IBA
08/2013
1Biological ProductsIBA
08/2013
1tyrosine receptor (receptor, tyrosine)IBA
07/2013
1ErbB Receptors (EGF Receptor)IBA
07/2013
1Phosphotransferases (Kinase)IBA
07/2013
1SynaptophysinIBA
05/2013
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
05/2013
1Parathyroid Hormone-Related ProteinIBA
01/2013
1pimonidazoleIBA
10/2012
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
10/2012
12-MethoxyestradiolIBA
10/2012
1Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
10/2012
1Capsules (Microcapsules)IBA
01/2012
1Differentiation AntigensIBA
01/2012
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
11/2010
1E2F1 Transcription FactorIBA
11/2010
1CollagenIBA
10/2009
1beta CateninIBA
02/2009
1CytokinesIBA
01/2008
1Interleukin-6 (Interleukin 6)IBA
01/2008
1Lipocalin-2IBA
01/2008
1Estrogens (Estrogen)FDA Link
01/2008
1Estradiol (Delestrogen)FDA LinkGeneric
01/2008
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2008
1AnabasineIBA
01/2008
1Cathepsin DIBA
01/2008
1hepsinIBA
08/2004
1Prostate-Specific Antigen (Semenogelase)IBA
08/2004
1Serine Proteases (Serine Protease)IBA
08/2004

Therapy/Procedure

9Castration
01/2021 - 08/2004
8Therapeutics
01/2021 - 08/2004
2Prostatectomy (Retropubic Prostatectomy)
01/2021 - 01/2020
1Solid-State Lasers
01/2020
1Radiotherapy
05/2014
1Ovariectomy (Oophorectomy)
10/2012
1Ligation
10/2009